Willingness to use drug checking within future supervised injection services among people who inject drugs in a mid-sized Canadian city

Drug and Alcohol Dependence - Tập 185 - Trang 248-252 - 2018
Mary Clare Kennedy1,2, Ayden Scheim3, Beth Rachlis4,5, Sanjana Mitra1,6, Geoff Bardwell1,7, Sean Rourke4,8, Thomas Kerr1,7
1British Columbia Centre on Substance Use, British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, 608-1081 Burrard Street, Vancouver, British Columbia, V6Z 1Y6, Canada
2School of Population and Public Health, University of British Columbia, 2206 E Mall, Vancouver, British Columbia, V6T 1Z3, Canada
3Department of Epidemiology and Biostatistics, The University of Western Ontario, Kresge Building, Room K201, London, Ontario, N6A 5C1, Canada
4Ontario HIV Treatment Network, 600-1300 Yonge Street, Toronto, Ontario, M4T 1X3, Canada
5Division of Clinical Public Health, Dalla Lana School of Public Health, Health Sciences Building, 155 College Street, 6th Floor, University of Toronto, Toronto, Ontario, N6A 5C1, Canada
6Interdisciplinary Studies, University of British Columbia, 270-2357 Main Mall, Vancouver, British Columbia, V6T 1Z4, Canada
7Department of Medicine, University of British Columbia, St. Paul’s Hospital, 608-1081 Burrard Street, Vancouver, British Columbia, V6Z 1Y6, Canada
8Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute of St. Michael’s Hospital, 209 Victoria Street, Toronto, Ontario, M5B 1T8, Canada

Tài liệu tham khảo

Archibald, 1998, Factors associated with frequent needle exchange program in injection drug users in Vancouver: Canada, JAIDS J. Acquir. Immune Defic. Syndr., 17, 160, 10.1097/00042560-199802010-00010 BC Overdose Action Exchange, 2016 Barratt, 2018, Pill testing or drug checking in Australia: acceptability of service design features, Drug Alcohol Rev., 37, 226, 10.1111/dar.12576 Bennett, 2011, Characteristics of an overdose prevention, response, and Naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania, J. Urban Health, 88, 1020, 10.1007/s11524-011-9600-7 Brunt, 2017, Drug testing in europe: monitoring results of the trans european drug information (TEDI) project: drug testing in europe, Drug Test. Anal., 9, 188, 10.1002/dta.1954 CBC News, 2017 CBC News, 2017 Canadian Centre on Substance Abuse (CCSA), 2015 Harper, 2017, An overview of forensic drug testing methods and their suitability for harm reduction point-of-care services, Harm. Reduct. J., 14, 52, 10.1186/s12954-017-0179-5 Health Canada, 2017 Health Canada, 2017 Kennedy, 2017, Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review, Curr. HIV/AIDS Rep., 14, 161, 10.1007/s11904-017-0363-y Kerr, 2007, Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users, Drug Alcohol Depend., 87, 39, 10.1016/j.drugalcdep.2006.07.009 Kerr, 2017, Supervised injection facilities in Canada: past, present, and future, Harm. Reduct. J., 14, 28, 10.1186/s12954-017-0154-1 Kerr, 2017 Lima, 2008, Differential impact of adherence on long-term treatment response among naive HIV-infected individuals, AIDS Lond. Engl., 22, 2371, 10.1097/QAD.0b013e328315cdd3 Lysyshn, 2017, Evaluation of a Fentanyl drug checking program for clients of a supervised injection site, Vancouver, Canada Marshall, 2011, Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: a retrospective population-based study, Lancet, 377, 1429, 10.1016/S0140-6736(10)62353-7 Martins, 2017, The detection and prevention of unintentional consumption of DOx and 25x-NBOMe at Portugal’s Boom Festival, Hum. Psychopharmacol. Clin. Exp., 32, 10.1002/hup.2608 Middlesex-London Health Unit, 2014 Public Health Ontario, 2017 Public Health Ontario, 2017 Road Safety Research Office, 2015 Scheim, 2017, Public drug injecting in London, Ontario: a cross-sectional survey, CMAJ Open, 5, E290, 10.9778/cmajo.20160163 Wood, 2006, Service uptake and characteristics of injection drug users utilizing North America’s first medically supervised safer injecting facility, Am. J. Public Health, 96, 770, 10.2105/AJPH.2004.057828